skip navigation

Investigative research on Long COVID

NIID is establishing scientific grounds for preparing measures to control Long COVID through an investigative research.

view more

Investigation on COVID-19 antibody positive rate

NIID prepares a basis for disease control policy by testing the antibodies generated through COVID-19 vaccination and natural infection.

view more
National Institute of Infectious Diseases

A control tower
for national infectious diseases research

to realize national health security against global infectious diseases

International cooperation with the National Institute of Allergy and Infectious Diseases (NIAID) of the US

NIID is strengthening research competency for emerging and variant infectious diseases through cooperation between national research institutes of Korea and US.

Development of therapeutic antibodies for COVID-19, MERS-CoV, and SFTS (severe fever with thrombocytopenia syndrome)

Having jointly developed a neutralizing antibody treatment for COVID-19 (Regdanvimab), NIID is continuously promoting R&D of therapeutic antibodies for infectious diseases.

Development of therapeutic antibodies for COVID-19, MERS-CoV, and SFTS (severe fever with thrombocytopenia syndrome)

Having jointly developed a neutralizing antibody treatment for COVID-19 (Regdanvimab), NIID is continuously promoting R&D of therapeutic antibodies for infectious diseases.

Designation as WHO collaborating center

The department of Antimicrobial Resistance Research affiliated with NIID has been designated as a WHO Collaborating Center named "WHO Collaborating Centre for AMR Reference and One Health Research" in 2021 and contributes to the surveillance and overcoming of antimicrobial resistance.

Cooperation with Moderna of the US for SFTS vaccine development

NIID is conducting a joint international study to develop a candidate for the SFTS mRNA vaccine.

Cooperation with Moderna of the US for SFTS vaccine development

NIID is conducting a joint international study to develop a candidate for the SFTS mRNA vaccine.

Research Outcomes

더보기

News

더보기